Stock 1BT ENLIVEX THERAPEUTICS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Enlivex Therapeutics Ltd. Deutsche Boerse AG

Equities

1BT

IL0011319527

Market Closed - Deutsche Boerse AG
Other stock markets
 11:30:12 28/06/2024 am IST 		5-day change 1st Jan Change
1.37 EUR +9.60% Intraday chart for Enlivex Therapeutics Ltd. +14.17% -40.43%
24/06 Enlivex Therapeutics Says First Patient Dosed in Phase 1/2 Thumb Osteoarthritis Trial MT
24/06 Enlivex Therapeutics Ltd. Announces the Dosing of the First Patient in a Randomized, Placebo-Controlled Phase I/II Trial Evaluating AllocetraTM in up to 46 Patients with Thumb Osteoarthritis CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HC Wainwright Adjusts Price Target on Enlivex Therapeutics to $6 From $7, Maintains Buy Rating
MT
HC Wainwright Adjusts Enlivex Therapeutics Price Target to $7 From $12, Maintains Buy Rating
MT
HC Wainwright Cuts Enlivex Therapeutics Price Target to $12 From $15, Maintains Buy Rating
MT
HC Wainwright Adjusts Enlivex Therapeutics' Price Target to $15 from $33, Keeps Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ENLV Stock
  4. 1BT Stock
  5. News Enlivex Therapeutics Ltd.
  6. Analyst Reco.